Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Cancer Metastatic × Ethiodized Oil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 20 Liver Neoplasms 2 Uveal Melanoma 1 Sarcoma 1 Recurrence Hepatocellular Carcinoma 1 Recurrence 1 Pleural Neoplasms 1 Pancreatic Adenocarcinoma 1 Neuroendocrine Tumors 1 Neoplastic Cells, Circulating 1 Mediastinal Neoplasms 1 Malignant Neoplasm in the Head and Neck 1 Lung Metastases 1 Hypoxia 1 HCC 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Bevacizumab 18 Capecitabine 15 Oxaliplatin 10 Cetuximab 10 Irinotecan 9 Fluorouracil 8 Panitumumab 6 Leucovorin 6 aflibercept 5 trifluridine tipiracil drug combination 3 sintilimab 3 regorafenib 3 Nivolumab 3 Vemurafenib 2 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2 Ipilimumab 2 Drug Therapy 2 spartalizumab 1 raltitrexed 1 pembrolizumab 1 masitinib 1 irinotecan sucrosofate 1 folfirinox 1 camrelizumab 1 balstilimab 1 atezolizumab 1 anisodamine 1 XELOX 1 Tyrosine Kinase Inhibitors 1 Tomography, X-Ray Computed 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01959061 2017-03-13

TACE

Nanjing Chia-tai Tianqing Pharmaceutical

Phase 4 Unknown

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡